These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 2411161)
21. [Granulocyte collection by intermittent flow centrifugation leukapheresis (IFC) and filtration leukapheresis (FL). Effects of high molecular hes and hydrocortisone on donors]. Suenaga T; Odaka K; Shiobara S; Sachimichi H; Mori T Rinsho Ketsueki; 1981 Oct; 22(10):1667-71. PubMed ID: 6174752 [No Abstract] [Full Text] [Related]
22. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158 [TBL] [Abstract][Full Text] [Related]
23. [Comparative study of the modification of blood, blood coagulation, cardiovascular circulation by 3% modified, fluid gelatins and 6% low-molecular weight hydroxyethyl starch]. Hopf HB; Siepmann HP Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():31-5. PubMed ID: 2439456 [TBL] [Abstract][Full Text] [Related]
24. [Improvement of the flow properties of the blood of patients by low-molecular hydroxyethyl starch (Expafusin)]. Landgraf H; Ruppel C; Saeger-Lorenz K; Vogel C; Ehrly AM Infusionsther Klin Ernahr; 1982 Aug; 9(4):202-6. PubMed ID: 6182099 [TBL] [Abstract][Full Text] [Related]
25. Effect of an equal volume replacement with 500 mL 6% hydroxyethyl starch on the blood and plasma volume of healthy volunteers. Mortelmans Y; Merckx E; van Nerom C; Verbruggen A; van Aken H; de Roo M; Mortelmans L Eur J Anaesthesiol; 1995 May; 12(3):259-64. PubMed ID: 7543845 [TBL] [Abstract][Full Text] [Related]
38. Less impairment of hemostasis and reduced blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline/hydroxyethyl starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution. Haas T; Fries D; Holz C; Innerhofer P; Streif W; Klingler A; Hanke A; Velik-Salchner C Anesth Analg; 2008 Apr; 106(4):1078-86, table of contents. PubMed ID: 18349176 [TBL] [Abstract][Full Text] [Related]
39. [Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)]. Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K Wien Klin Wochenschr; 1996; 108(1):20-3. PubMed ID: 8677658 [TBL] [Abstract][Full Text] [Related]
40. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects. de Jonge E; Levi M; Büller HR; Berends F; Kesecioglu J Intensive Care Med; 2001 Nov; 27(11):1825-9. PubMed ID: 11810130 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]